Updates are available Correction dated 2019-10-23
Click to view Correction: https://doi.org/10.1007/s10620-019-05876-0
-
Authors
Yarur, Andres J. https://orcid.org/0000-0003-2293-5555
Bruss, Alexandra
Naik, Snehal
Beniwal-Patel, Poonam
Fox, Caroline
Jain, Anjali
Berens, Brandon
Patel, Amir
Ungaro, Ryan
Bahur, Bayda
Dubinsky, Marla
Stein, Daniel J.
-
Funding
Funding for this research was provided by:
Prometheus Laboratories
- License Information
-
More Information
Article History
Received: 7 January 2019
Accepted: 26 February 2019
First Online: 5 March 2019
Change Date: 23 October 2019
Change Type: Correction
Change Details: The original version of the article unfortunately contained a couple of errors. In ‘methods’ section, in ‘Outcomes’ subsection, the sentence 'Endoscopic remission was defined as an SESCD ≤ 2 in patients with CD and an EMS ≤ 2 in UC patients while off corticosteroids.’
Compliance with ethical standards
:
: Andres J. Yarur, MD is a consultant, has received research support and is part of the speaker bureau for Takeda pharmaceuticals, Abbvie and Prometheus Laboratories. Alexandra Bruss, CRC, Caroline Fox, PAC, Amir Patel MD and Brandon Berens CRC have no conflict of interests to report. Poonam Beniwal-Patel, MD is part of the speaker bureau of Takeda pharmaceuticals. Snehal Naik, PhD, Anjali Jain PhD and Bayda Bahur are employees of Prometheus Laboratories. Ryan Ungaro, MD has been part of consulting/advisory board for Takeda, Janssen and Pfizer. He has also received research grant support from Abbvie. Marla Dubinsky, MD is a consultant for Takeda pharmaceuticals and Prometheus Laboratories. Daniel J. Stein, MD is part of the speaker bureau for Takeda pharmaceuticals, Janssen and Abbvie.
